Mirum Pharmaceuticals Inc (MIRM)
43.96
+1.68
(+3.96%)
USD |
NASDAQ |
Nov 13, 16:00
43.96
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Revenue (Annual): 186.37M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 186.37M |
December 31, 2022 | 77.06M |
Date | Value |
---|---|
December 31, 2021 | 19.14M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
19.14M
Minimum
2021
186.37M
Maximum
2023
94.19M
Average
77.06M
Median
2022
Revenue (Annual) Benchmarks
Arcutis Biotherapeutics Inc | 59.61M |
Cytokinetics Inc | 7.53M |
Amicus Therapeutics Inc | 399.36M |
MannKind Corp | 198.96M |
TG Therapeutics Inc | 233.66M |